Skip to content
Screener

Myriad Genetics MYGN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$678M+3.5%
NeoGenomics logo
NeoGenomicsNEO
$78.61M-5.1%
Veracyte logo
VeracyteVCYT
11.4%0.0pp
Sera Prognostics logo
Sera PrognosticsSERA
8.8%+1.3pp
Guardant Health logo
Guardant HealthGH
4.5%+0.7pp
Natera, Inc. logo
Natera, Inc.NTRA
6.6%-9,512,800,258pp

Segments

By geography

See full
West Salt Lake City$2.7M

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$310.86M-46.0%
Enterprise value$396.36M-38.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 6:05 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000899923-26-000038
Line itemMarch 31,2026December 31,2025
Prepaid taxes2.012.0
Prepaid expenses and other current assets34.725.1
Total current assets312.8332.6
Operating lease right-of-use assets51.049.4
Property, plant and equipment, net111.5114.0
Intangible assets, net145.7153.4
Goodwill47.151.6
Other assets5.65.6

Item 1. Financial Statements.

FAQ

What is Myriad Genetics's operating lease ROU assets?
Myriad Genetics (MYGN) reported operating lease ROU assets of $51M in Q1 2026.
How has Myriad Genetics's operating lease ROU assets changed year-over-year?
Myriad Genetics's operating lease ROU assets decreased by 4.5% year-over-year, from $53.4M to $51M.
What is the long-term trend for Myriad Genetics's operating lease ROU assets?
Over 5 years (2020 to 2025), Myriad Genetics's operating lease ROU assets has grown at a -3.7% compound annual growth rate (CAGR), from $59.7M to $49.4M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Myriad Genetics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude